For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Relmada Therapeutics Inc (NASDAQ: RLMD) closed the day trading at $0.36 up 0.11% from the previous closing price of $0.36. In other words, the price has increased by $0.11 from its previous closing price. On the day, 0.61 million shares were traded. RLMD stock price reached its highest trading level at $0.3823 during the session, while it also had its lowest trading level at $0.3502.
Ratios:
For a better understanding of RLMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.89 and its Current Ratio is at 6.89. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on December 05, 2024, Downgraded its rating to Neutral and sets its target price to $1 from $23 previously.
On September 17, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $3.50 to $13.
Goldman Downgraded its Neutral to Sell on June 05, 2024, whereas the target price for the stock was revised from $3 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’24 when TRAVERSA SERGIO bought 51,407 shares for $2.99 per share. The transaction valued at 153,707 led to the insider holds 384,024 shares of the business.
TRAVERSA SERGIO bought 55,579 shares of RLMD for $150,619 on Sep 09 ’24. The Chief Executive Officer now owns 299,603 shares after completing the transaction at $2.71 per share. On Sep 10 ’24, another insider, TRAVERSA SERGIO, who serves as the Chief Executive Officer of the company, bought 33,014 shares for $2.75 each. As a result, the insider paid 90,788 and bolstered with 332,617 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLMD now has a Market Capitalization of 11007548 and an Enterprise Value of 27930570.
Stock Price History:
The Beta on a monthly basis for RLMD is 0.49, which has changed by -0.92017543 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, RLMD has reached a high of $7.22, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is -65.74%, while the 200-Day Moving Average is calculated to be -86.88%.
Shares Statistics:
Over the past 3-months, RLMD traded about 1.06M shares per day on average, while over the past 10 days, RLMD traded about 352150 shares per day. A total of 30.17M shares are outstanding, with a floating share count of 25.28M. Insiders hold about 16.22% of the company’s shares, while institutions hold 38.42% stake in the company. Shares short for RLMD as of 1728950400 were 1255763 with a Short Ratio of 1.18, compared to 1726185600 on 1179677. Therefore, it implies a Short% of Shares Outstanding of 1255763 and a Short% of Float of 4.2299999999999995.
